The Indian Serum Institute said on Tuesday (April 28) that it plans to produce up to 60 million doses of potential vaccines against new coronaviruses this year, and the vaccine is undergoing clinical trials in Britain.
Serum is the world’s largest vaccine manufacturer. It is mass-producing the candidate vaccine developed by Oxford University. The vaccine was tested in humans last week and is the leader of a global competition to develop new coronavirus antidote.
According to Reuters tally, it is reported that approximately 3.05 million people are infected worldwide, and 211,376 people died of COVID-19, a respiratory disease caused by coronavirus.
The Oxford vaccine, called “ChAdOx1 nCoV-19”, has not been proven to work against COVID-19, but due to its success in animal testing and testing in humans, the serum company decided to start producing the vaccine. Adar Poonawalla said.
At present, biotechnology and research teams around the world are developing up to 100 potential COVID-19 vaccine candidates, at least five of which are in the preliminary testing of the so-called Phase 1 clinical trials.